UCLA/VA partners with ASU to advance biosensor technology for urinary tract infections

[Source: Eureka Alert] — NIH award will help team develop a faster, more sensitive product to test for infection. Researchers from the David Geffen School of Medicine at UCLA, the Veterans Affairs Greater Los Angeles Healthcare System, GeneFluidics Inc. and the Biodesign Institute at Arizona State University have received a five-year, $3.2 million award from the National Institutes of Health to help rapidly diagnose and treat urinary tract infections